Alkermes Plc (ALKS)
45.99
-0.19
(-0.41%)
USD |
NASDAQ |
Nov 20, 11:52
Alkermes Free Cash Flow : 227.37M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 227.37M |
| June 30, 2026 | 221.65M |
| March 31, 2026 | 221.80M |
| December 31, 2025 | 480.33M |
| September 30, 2025 | 490.87M |
| June 30, 2025 | 479.84M |
| March 31, 2025 | 481.58M |
| December 31, 2024 | 405.64M |
| September 30, 2024 | 315.22M |
| June 30, 2024 | 327.15M |
| March 31, 2024 | 394.23M |
| December 31, 2023 | 353.30M |
| September 30, 2023 | 254.12M |
| June 30, 2023 | 159.01M |
| March 31, 2023 | -59.26M |
| December 31, 2022 | -17.21M |
| September 30, 2022 | 14.13M |
| June 30, 2022 | 101.94M |
| March 31, 2022 | 139.71M |
| December 31, 2021 | 72.70M |
| September 30, 2021 | 112.24M |
| June 30, 2021 | 88.07M |
| March 31, 2021 | 47.56M |
| December 31, 2020 | 40.62M |
| September 30, 2020 | -11.18M |
| Date | Value |
|---|---|
| June 30, 2020 | -53.43M |
| March 31, 2020 | -77.51M |
| December 31, 2019 | -18.86M |
| September 30, 2019 | 13.96M |
| June 30, 2019 | 19.48M |
| March 31, 2019 | 73.75M |
| December 31, 2018 | 29.85M |
| September 30, 2018 | 5.018M |
| June 30, 2018 | -5.388M |
| March 31, 2018 | -54.30M |
| December 31, 2017 | -32.11M |
| September 30, 2017 | -55.94M |
| June 30, 2017 | -59.37M |
| March 31, 2017 | -64.79M |
| December 31, 2016 | -110.89M |
| September 30, 2016 | -118.88M |
| June 30, 2016 | -163.52M |
| March 31, 2016 | -153.83M |
| December 31, 2015 | -93.24M |
| September 30, 2015 | -79.19M |
| June 30, 2015 | -54.46M |
| March 31, 2015 | -21.99M |
| December 31, 2014 | -22.51M |
| September 30, 2014 | 5.42M |
| June 30, 2014 | 10.87M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amarin Corp. Plc | 37.53M |
| Prothena Corp. Plc | -30.75M |
| Cue Biopharma, Inc. | -51.22M |
| ACADIA Pharmaceuticals, Inc. | 81.99M |
| Alnylam Pharmaceuticals, Inc. | 752.13M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 93.48M |
| Cash from Investing (Quarterly) | 19.99M |
| Cash from Financing (Quarterly) | 6.318M |
| Free Cash Flow Per Share (Quarterly) | 0.5107 |
| Free Cash Flow to Equity (Quarterly) | 91.56M |
| Free Cash Flow to Firm (Quarterly) | 120.52M |
| Free Cash Flow Yield | 2.94% |